Hanger Helmet Study
NCT02561728 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2016-06-29
Summary
The purpose of this study is to examine a group of patients requiring helmet therapy (either patients with plagiocephaly or post-surgical patients) to compare outcomes of infants treated with the Hanger helmet (Hanger, Inc.) to outcomes of infants treated with the P Pod Helmet (Lorica Scientific, LLC). Currently both helmets are prescribed at CCHMC. The investigators' goal is to determine which helmet is more effective in skull remodeling and to standardize the investigators' care for these patient types.
Conditions
- Plagiocephaly
- Craniosynostosis
Interventions
- DEVICE
-
Hangar Helmet
Child will be fitted with the Hangar Helmet
- DEVICE
-
P-Pod Helmet
Child will be fitted with the P-Pod Helmet
Sponsors & Collaborators
-
Children's Hospital Medical Center, Cincinnati
lead OTHER
Principal Investigators
-
John van Aalst, MD · Children's Hospital Medical Center, Cincinnati
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Max Age
- 10 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-31
- Primary Completion
- 2022-10-31
- Completion
- 2023-10-31
More Related Trials
-
Growth Hormone Treatment in Children With Hypophosphatemic Rickets
NCT02720770 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Early hGH Treatment of SGA Infants to Prevent Irreversible Neurologic and Psychological Damage and Sequelae
NCT02326610 ·Status: UNKNOWN ·Phase: PHASE2
-
Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age
NCT00174460 ·Status: COMPLETED ·Phase: PHASE2
-
Retrospective Study Of The Influence Of Age At Start Of Growth Hormone Treatment On Height Gain In Children Born Small for Gestational Age
NCT01897753 ·Status: COMPLETED
-
Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children
NCT02314676 ·Status: UNKNOWN ·Phase: PHASE4
-
Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy
NCT00174291 ·Status: TERMINATED ·Phase: PHASE3
-
National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients
NCT00097513 ·Status: COMPLETED
-
Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy
NCT00174187 ·Status: TERMINATED ·Phase: PHASE3
-
Prospective Clinical Assessment Study in Children With Hypochondroplasia
NCT06410976 ·Status: RECRUITING
-
rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency
NCT00572156 ·Status: TERMINATED ·Phase: PHASE2
-
Acromegaly Combination Treatment Study
NCT01538966 ·Status: TERMINATED ·Phase: NA
-
Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children
NCT00102817 ·Status: COMPLETED ·Phase: PHASE3
-
304-C03/L3301n: Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency
NCT00362063 ·Status: UNKNOWN ·Phase: NA
-
Constructing an Insulin-Like Growth Factor-based Prediction Model
NCT00263445 ·Status: TERMINATED
-
Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction
NCT00519844 ·Status: COMPLETED ·Phase: PHASE4
-
Metabolic and QOL Effects of GH Treatment in Patients With TBI and AGHD
NCT02988687 ·Status: COMPLETED
-
Growth Hormone Deficiency in Mild Traumatic Brain Injury
NCT05660356 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Study of Growth-promoting and Metabolic Effects of Growth Hormone (rhGH)
NCT00597480 ·Status: TERMINATED ·Phase: PHASE4
-
Treatment of Children With Insufficient Secretion of Growth Hormone
NCT00271518 ·Status: UNKNOWN ·Phase: PHASE3
-
Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age
NCT00174408 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)
NCT04035811 ·Status: COMPLETED
-
Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone
NCT01327924 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury
NCT00638053 ·Status: TERMINATED ·Phase: PHASE4
-
Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficiency
NCT00125164 ·Status: COMPLETED ·Phase: PHASE3
-
Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
NCT02616562 ·Status: COMPLETED ·Phase: PHASE2